Modulation of cytokine production by cyclic adenosine monophosphate analogs in human leukocytes

Journal of Interferon and Cytokine Research

Volumn 30, Issue 12, 2010, Pages 883-891

  Gerlo, Sarah ^a   Verdood, Peggy ^b   Kooijman, Ron ^b  

^a GHENT UNIVERSITY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

8 (4 CHLOROPHENYL THIO) 2 O METHYL CYCLIC AMP; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; N6 BENZOYLADENOSINE CYCLIC AMP; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION;

CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYTOKINES; HUMANS; LYMPHOCYTES;

EID: 78650018958     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2009.0021     Document Type: Article

References (42)

1. Aandahl EM, Moretto WJ, Haslett PA, Vang T, Bryn T, Tasken K, Nixon DF. 2002. Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J Immunol 169(2):802-808.
2. Aronoff DM, Canetti C, Serezani CH, Luo M, Peters-Golden M. 2005. Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J Immunol 174(2): 595-599.
3. Benbernou N, Esnault S, Shin HC, Fekkar H, Guenounou M. 1997. Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway. Immunology 91(3):361-368.
4. Borger P, Postma DS, Vellenga E, Kauffman HF. 2000. Regulation of asthma-related T-cell cytokines by the cyclic AMPdependent signalling pathway. Clin Exp Allergy 30(7):920-926.
5. Bryn T, Mahic M, Enserink JM, Schwede F, Aandahl EM, Tasken K. 2006. The cyclic AMP-Epac1-Rap1 pathway is dissociated from regulation of effector functions in monocytes but acquires immunoregulatory function in mature macrophages. J Immunol 176(12):7361-7370.
6. Cho JY, Park JS, Baik KU, Lee JG, Kim HP, Yoo ES, Park MH. 2004. Differential effect of phosphodiesterase IV inhibitor RP73401 on various inflammatory and immune responses relevant to rheumatoid arthritis. Pharmacol Res 49(5):423-431.
7. Christensen AE, Selheim F, de Rooij J, Dremier S, Schwede F, Dao KK, Martinez A, Maenhaut C, Bos JL, Genieser HG, Doskeland SO. 2003. cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J Biol Chem 278(37):35394-35402.
8. Cole SW, Korin YD, Fahey JL, Zack JA. 1998. Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol 161(2):610-616.
9. Dastidar SG, Rajagopal D, Ray A. 2007. Therapeutic benefit of PDE4 inhibitors in inflammatory diseases. Curr Opin Investig Drugs 8(5):364-372.
10. Delgado M, Abad C, Martinez C, Leceta J, Gomariz RP. 2001. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med 7(5):563-568.
11. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. 1998. Epac is a Rap1 guanine-nucleotideexchange factor directly activated by cyclic AMP. Nature 396(6710):474-477.
12. Du K, Montminy M. 1998. CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273(49):32377-32379.
13. El Zein N, Badran B, Sariban E. 2008. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1. J Leukoc Biol 83(4):972-981.
14. Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Doskeland SO, Blank JL, Bos JL. 2002. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 4(11):901-906.
15. Foey AD, Field S, Ahmed S, Jain A, Feldmann M, Brennan FM, Williams R. 2003. Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis. Arthritis Res Ther 5(6):R317-R328.
16. Gerlo S, Verdood P, Hooghe-Peters E, Kooijman R. 2006a. Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells. Cell Mol Life Sci 63(1):92-99.
17. Gerlo S, Verdood P, Hooghe-Peters EL, Kooijman R. 2005. Multiple, PKA-dependent and PKA-independent, signals are involved in cAMP-induced PRL expression in the eosinophilic cell line Eol-1. Cell Signal 17(7):901-909.
18. Gerlo S, Verdood P, Hooghe-Peters EL, Kooijman R. 2006b. Multiple cAMP-induced signaling cascades regulate prolactin expression in T cells. Cell Mol Life Sci 63(1):92-99.
19. Gmelig Meyling F, Uytdehaag ACGM, Ballieux RE. 1977. Human B activation in vitro. T dependent pokeweed mitogeninduced differentiation of blood B lymphocytes. Cell Immunol 33:156-169.
20. Holm AM, Aukrust P, Aandahl EM, Muller F, Tasken K, Froland SS. 2003. Impaired secretion of IL-10 by T cells from patients with common variable immunodeficiency-involvement of protein kinase A type I. J Immunol 170(11):5772-5777.
21. Kooijman R, Coppens A. 2004. Insulin-like growth factor-I stimulates IL-10 production in human T cells. J Leukoc Biol 76:862-867.
22. Kooijman R, Coppens A, Hooghe-Peters EL. 2002. Insulin-like growth factor-I inhibits spontaneous apoptosis in human granulocytes. Endocrinology 143:1206-1212.
23. Liopeta K, Boubali S, Virgilio L, Thyphronitis G, Mavrothalassitis G, Dimitracopoulos G, Paliogianni F. 2009. cAMP regulates IL-10 production by normal human T lymphocytes at multiple levels: a potential role for MEF2. Mol Immunol 46(3):345-354.
24. Lipworth BJ. 2005. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet 365(9454): 167-175.
25. Lorenowicz MJ, van Gils J, de Boer M, Hordijk PL, Fernandez- Borja M. 2006. Epac1-Rap1 signaling regulates monocyte adhesion and chemotaxis. J Leukoc Biol 80(6):1542-1552.
26. Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2(8):599-609.
27. McPhee I, Gibson LCD, Kewney J, Darroch C, Stevens PA, Spinks D, Cooreman A, MacKenzie SJ. 2005. Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimers disease. Biochem Soc Trans 33(Pt 6):1330-1332.
28. Mei FC, Qiao J, Tsygankova OM, Meinkoth JL, Quilliam LA, Cheng X. 2002. Differential signaling of cyclic AMP: opposing effects of exchange protein directly activated by cyclic AMP and cAMP-dependent protein kinase on protein kinase B activation. J Biol Chem 277(13):11497-11504.
29. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. 2001. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19:683-765.
30. Ogreid D, Ekanger R, Suva RH, Miller JP, Doskeland SO. 1989. Comparison of the two classes of binding sites (A and B) of type I and type II cyclic-AMP-dependent protein kinases by using cyclic nucleotide analogs. Eur J Biochem 181(1):19-31.
31. Park PH, Huang H, McMullen MR, Bryan K, Nagy LE. 2008. Activation of cyclic-AMP response element binding protein contributes to adiponectin- stimulated interleukin-10 expression in raw 264.7 macrophages. J Leukoc Biol 83(5): 1258-1266.
32. Platzer C, Docke W, Volk H, Prosch S. 2000. Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J Neuroimmunol 105(1):31-38.
33. Romagnani S. 1991. Human TH1 and TH2 subsets: doubt no more. Immunol Today 12(8):256-257.
34. Spina D. 2004. The potential of PDE4 inhibitors in respiratory disease. Curr Drug Targets Inflamm Allergy 3(3):231-236.
35. Spina D. 2008. PDE4 inhibitors: current status. Br J Pharmacol 155(3):308-315.
36. Staples KJ, Bergmann M, Tomita K, Houslay MD, McPhee I, Barnes PJ, Giembycz MA, Newton R. 2001. Adenosine 30,50- cyclic monophosphate (cAMP)-dependent inhibition of IL-5 from human T lymphocytes is not mediated by the cAMPdependent protein kinase A. J Immunol 167(4):2074-2080.
37. Tiwari S, Felekkis K, Moon EY, Flies A, Sherr DH, Lerner A. 2004. Among circulating hematopoietic cells, B-CLL uniquely expresses functional EPAC1, but EPAC1-mediated Rap1 activation does not account for PDE4 inhibitor-induced apoptosis. Blood 103(7):2661-2667.
38. Van Valckenborgh E, Bakkus M, Munaut C, Noel A, St PY, Asosingh K, Van RI, Van CB, Vanderkerken K. 2002. Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells. Int J Cancer 101(6):512-518.
39. Wall EA, Zavzavadjian JR, Chang MS, Randhawa B, Zhu X, Hsueh RC, Liu J, Driver A, Bao XR, Sternweis PC, Simon MI, Fraser ID. 2009. Suppression of LPS-induced TNF-alpha production in macrophages by cAMP is mediated by PKAAKAP95- p105. Sci Signal 2(75):ra28.
40. Whelan CJ. 2003. Will non-steroid approaches to the treatment of inflammation replace our need for glucocorticoids? Curr Opin Investig Drugs 4(5):536-543.
41. Yang BC, Lin HK, Hor WS, Hwang JY, Lin YP, Liu MY, Wang YJ. 2003. Mediation of enhanced transcription of the IL-10 gene in T cells, upon contact with human glioma cells, by Fas signaling through a protein kinase A-independent pathway. J Immunol 171(8):3947-3954.
42. Zhou W, Blackwell TS, Goleniewska K, ONeal JF, Fitzgerald GA, Lucitt M, Breyer RM, Peebles RS Jr. 2007. Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells. J Leukoc Biol 81(3):809-817.